​

Funding Round

Series D - Mitralign

Series D - Mitralign

Investment Firm

Overview

Mitralign is focused on developing a catheter-based technology for the percutaneous treatments of functional mitral regurgitation.

Announced Date

May 16, 2012

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

Forbion Capital Partners

Forbion Capital Partners

Forbion Capital Partners is a early_stage_venture and post_ipo and seed firm.

Participant Investors

6

Investor Name
Participant InvestorForbion Capital Partners
Participant InvestorJohnson & Johnson Development Corporation
Participant InvestorMedtronic
Participant InvestorSaints Capital
Participant InvestorTriathlon Medical Venture Partners

Round Details and Background

Mitralign raised $35000000 on 2012-05-16 in Series D

Mitralign is focused on developing a catheter-based technology for the percutaneous treatments of functional mitral regurgitation.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 31, 2007
Series C - Mitralign
8-24.0M
Jun 20, 2014
Venture Round - Mitralign
1-8.0M
Sep 11, 2012
Debt Financing - Mitralign
-7.0M
May 16, 2012
Series D - Mitralign
6-35.0M

Recent Activity

There is no recent news or activity for this profile.